BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 31015004)

  • 41. Graphene-like Metal-Free 2D Nanosheets for Cancer Imaging and Theranostics.
    Luo Y; Li Z; Zhu C; Cai X; Qu L; Du D; Lin Y
    Trends Biotechnol; 2018 Nov; 36(11):1145-1156. PubMed ID: 29954613
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanobiotechnology of Carbon Dots: A Review.
    Durán N; Simões MB; de Moraes ACM; Fávaro WJ; Seabra AB
    J Biomed Nanotechnol; 2016 Jul; 12(7):1323-47. PubMed ID: 29336531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carbon nanomaterials combined with metal nanoparticles for theranostic applications.
    Modugno G; Ménard-Moyon C; Prato M; Bianco A
    Br J Pharmacol; 2015 Feb; 172(4):975-91. PubMed ID: 25323135
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy.
    Peng F; Su Y; Zhong Y; Fan C; Lee ST; He Y
    Acc Chem Res; 2014 Feb; 47(2):612-23. PubMed ID: 24397270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activatable Theranostics.
    Huang P
    Curr Med Chem; 2019; 26(8):1310. PubMed ID: 31189459
    [No Abstract]   [Full Text] [Related]  

  • 47. Polyvalent Nanoobjects for Precision Diagnostics.
    Omstead DT; Sjoerdsma J; Bilgicer B
    Annu Rev Anal Chem (Palo Alto Calif); 2019 Jun; 12(1):69-88. PubMed ID: 30811215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Versatile carbon nanoplatforms for cancer treatment and diagnosis: strategies, applications and future perspectives.
    Tang L; Li J; Pan T; Yin Y; Mei Y; Xiao Q; Wang R; Yan Z; Wang W
    Theranostics; 2022; 12(5):2290-2321. PubMed ID: 35265211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbon Dots as Nanotherapeutics for Biomedical Application.
    Cohen EN; Kondiah PPD; Choonara YE; du Toit LC; Pillay V
    Curr Pharm Des; 2020; 26(19):2207-2221. PubMed ID: 32238132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Function-driven engineering of 1D carbon nanotubes and 0D carbon dots: mechanism, properties and applications.
    Xu Q; Li W; Ding L; Yang W; Xiao H; Ong WJ
    Nanoscale; 2019 Jan; 11(4):1475-1504. PubMed ID: 30620019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanomaterials for theranostics: recent advances and future challenges.
    Lim EK; Kim T; Paik S; Haam S; Huh YM; Lee K
    Chem Rev; 2015 Jan; 115(1):327-94. PubMed ID: 25423180
    [No Abstract]   [Full Text] [Related]  

  • 52. Red-Emissive Carbon Dots for Fluorescent, Photoacoustic, and Thermal Theranostics in Living Mice.
    Ge J; Jia Q; Liu W; Guo L; Liu Q; Lan M; Zhang H; Meng X; Wang P
    Adv Mater; 2015 Jul; 27(28):4169-77. PubMed ID: 26045099
    [No Abstract]   [Full Text] [Related]  

  • 53. Emerging two-dimensional monoelemental materials (Xenes) for biomedical applications.
    Tao W; Kong N; Ji X; Zhang Y; Sharma A; Ouyang J; Qi B; Wang J; Xie N; Kang C; Zhang H; Farokhzad OC; Kim JS
    Chem Soc Rev; 2019 Jun; 48(11):2891-2912. PubMed ID: 31120049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantum dots in nanomedicine: recent trends, advances and unresolved issues.
    Volkov Y
    Biochem Biophys Res Commun; 2015 Dec; 468(3):419-27. PubMed ID: 26168726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Facile Synthesis of Fluorescent Hyper-Cross-Linked β-Cyclodextrin-Carbon Quantum Dot Hybrid Nanosponges for Tumor Theranostic Application with Enhanced Antitumor Efficacy.
    Pei M; Pai JY; Du P; Liu P
    Mol Pharm; 2018 Sep; 15(9):4084-4091. PubMed ID: 30040427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional Carbon Quantum Dots for Ocular Imaging and Therapeutic Applications.
    Kumar VB; Sher I; Rencus-Lazar S; Rotenstreich Y; Gazit E
    Small; 2023 Feb; 19(7):e2205754. PubMed ID: 36461689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy.
    Medina-Reyes EI; Garcia-Viacobo D; Carrero-Martinez FA; Chirino YI
    Crit Rev Ther Drug Carrier Syst; 2017; 34(1):35-61. PubMed ID: 28322140
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
    Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
    Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
    [No Abstract]   [Full Text] [Related]  

  • 59. Carbon-based hybrid nanogels: a synergistic nanoplatform for combined biosensing, bioimaging, and responsive drug delivery.
    Wang H; Chen Q; Zhou S
    Chem Soc Rev; 2018 Jun; 47(11):4198-4232. PubMed ID: 29667656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carbon dots: A novel trend in pharmaceutical applications.
    Dugam S; Nangare S; Patil P; Jadhav N
    Ann Pharm Fr; 2021 Jul; 79(4):335-345. PubMed ID: 33383021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.